New WHO classification of pituitary adenomas (4th edition): assessment of pituitary transcription factors and the prognostic histological factors
Brain Tumor Pathology · 2018-04 · 35 (2) · 57-61
DOI: 10.1007/s10014-017-0307-7 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Brain Tumor Pathology, online erschienen am 09.01.2018. Verfasst von Hiroshi Nishioka und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hypothalamic and Pituitary Surgery, Toranomon Hospital, 2-2-2 Toranomon, Minatoku, Tokyo, 105-8470, Japan. nishioka@tokyo-med.ac.jp. Hauptthemen laut MEDLINE: Transcription Factors, World Health Organization. Die Arbeit wurde bisher 82-mal zitiert (Crossref) und nennt 14 Literaturangaben.
Abstract (Originalsprache)
WHO classification of pituitary adenomas was revised in 2017. The two major and significant changes are discussed. (1) The new classification focuses on adenohypophysial-cell lineage for the designation of adenomas, and thus, assessment of pituitary transcription factors is recommended. Its appropriate use has a complementary role in obtaining an accurate diagnosis, particularly in hormone-negative adenomas. Subclassification of nonfunctioning adenomas was revised accordingly and, consequently, null cell adenomas became quite rare. (2) "Atypical adenoma", a previous category, was eliminated due to the poor reproducibility and predictive value. Assessment of tumor proliferation marker and other clinical parameters such as invasion are recommended to predict aggressiveness. "High-risk adenomas" are those with rapid growth, radiological invasion, and a high Ki-67 proliferation index, whereas some special adenoma subtypes commonly show aggressive behavior.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hypothalamic and Pituitary Surgery, Toranomon Hospital, 2-2-2 Toranomon, Minatoku, Tokyo, 105-8470, Japan. nishioka@tokyo-med.ac.jp.
- Okinaka Memorial Institute for Medical Research, Tokyo, Japan. nishioka@tokyo-med.ac.jp.
- Department of Pathology, Toranomon Hospital, Tokyo, Japan.
- Okinaka Memorial Institute for Medical Research, Tokyo, Japan.
Zitieren
APA
Nishioka, H., & Inoshita, N. (2018). New WHO classification of pituitary adenomas (4th edition): assessment of pituitary transcription factors and the prognostic histological factors. Brain Tumor Pathology, 35(2), 57-61. https://doi.org/10.1007/s10014-017-0307-7
Vancouver
Nishioka H, Inoshita N. New WHO classification of pituitary adenomas (4th edition): assessment of pituitary transcription factors and the prognostic histological factors. Brain Tumor Pathology. 2018;35(2):57-61. doi:10.1007/s10014-017-0307-7
BibTeX
@article{Nishioka2018,
author = {Nishioka, Hiroshi and Inoshita, Naoko},
title = {New WHO classification of pituitary adenomas (4th edition): assessment of pituitary transcription factors and the prognostic histological factors},
journal = {Brain Tumor Pathology},
year = {2018},
volume = {35},
number = {2},
pages = {57--61},
doi = {10.1007/s10014-017-0307-7}
}
EUVIMED